NO20016099L - Optisk aktive pyrrolopyridazinforbindelser - Google Patents

Optisk aktive pyrrolopyridazinforbindelser

Info

Publication number
NO20016099L
NO20016099L NO20016099A NO20016099A NO20016099L NO 20016099 L NO20016099 L NO 20016099L NO 20016099 A NO20016099 A NO 20016099A NO 20016099 A NO20016099 A NO 20016099A NO 20016099 L NO20016099 L NO 20016099L
Authority
NO
Norway
Prior art keywords
optically active
compounds
activity against
active pyrrolopyridazine
alkyl
Prior art date
Application number
NO20016099A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016099D0 (no
Inventor
Masahiko Hagihara
Nobuhiko Shibakawa
Keiji Matsunobu
Hiroshi Fujiwara
Keiichi Ito
Original Assignee
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries filed Critical Ube Industries
Publication of NO20016099D0 publication Critical patent/NO20016099D0/no
Publication of NO20016099L publication Critical patent/NO20016099L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
NO20016099A 1999-06-15 2001-12-14 Optisk aktive pyrrolopyridazinforbindelser NO20016099L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16767999 1999-06-15
PCT/JP2000/003895 WO2000077003A1 (en) 1999-06-15 2000-06-15 Optically active pyrrolopyridazine compounds

Publications (2)

Publication Number Publication Date
NO20016099D0 NO20016099D0 (no) 2001-12-14
NO20016099L true NO20016099L (no) 2002-02-07

Family

ID=15854223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016099A NO20016099L (no) 1999-06-15 2001-12-14 Optisk aktive pyrrolopyridazinforbindelser

Country Status (25)

Country Link
US (1) US6670360B2 (de)
EP (1) EP1186607B1 (de)
KR (1) KR100583663B1 (de)
CN (1) CN1170829C (de)
AT (1) ATE240957T1 (de)
AU (1) AU757611B2 (de)
BR (1) BR0011666A (de)
CA (1) CA2375848A1 (de)
CZ (1) CZ290935B6 (de)
DE (1) DE60002860T2 (de)
DK (1) DK1186607T3 (de)
ES (1) ES2198319T3 (de)
HK (1) HK1044341B (de)
HU (1) HUP0201434A3 (de)
IL (2) IL147088A0 (de)
MX (1) MXPA01013011A (de)
NO (1) NO20016099L (de)
NZ (1) NZ516194A (de)
PL (1) PL356479A1 (de)
PT (1) PT1186607E (de)
RU (1) RU2222541C2 (de)
TR (1) TR200103685T2 (de)
TW (1) TWI287014B (de)
WO (1) WO2000077003A1 (de)
ZA (1) ZA200110279B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100750551B1 (ko) 2000-02-10 2007-08-20 상꾜 가부시키가이샤 피롤로피리다진 화합물
AU2003266621A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for treatment for or prevention of visceral pain
AU2003266622A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for inhibiting increase in blood gastrin concentration
WO2005041961A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
US7642269B2 (en) 2004-09-03 2010-01-05 Yuhan Corporation Pyrrolo[3,2-B]pyridine derivatives and processes for the preparation thereof
CN101003537A (zh) * 2006-01-17 2007-07-25 上海恒瑞医药有限公司 吡咯并哒嗪类衍生物及其制备方法和用途
US8648080B2 (en) 2009-07-09 2014-02-11 Raqualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7754691A (en) 1990-04-27 1991-11-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel pyridazines
WO1992006979A1 (de) 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
WO1993008190A1 (de) 1991-10-25 1993-04-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrrolo-pyridazine mit magen- und darmschutzwirkungen
DE69529056T2 (de) 1994-01-19 2003-11-13 Sankyo Co., Ltd. Pyrrolopyridazin-derivate

Also Published As

Publication number Publication date
AU757611B2 (en) 2003-02-27
HK1044341A1 (en) 2002-10-18
HUP0201434A3 (en) 2003-09-29
ATE240957T1 (de) 2003-06-15
PT1186607E (pt) 2003-08-29
MXPA01013011A (es) 2002-11-07
EP1186607A4 (de) 2002-07-03
IL147088A0 (en) 2002-08-14
EP1186607A1 (de) 2002-03-13
TWI287014B (en) 2007-09-21
EP1186607B1 (de) 2003-05-21
NZ516194A (en) 2003-03-28
HK1044341B (en) 2003-10-03
BR0011666A (pt) 2002-03-19
US20020156079A1 (en) 2002-10-24
AU5426900A (en) 2001-01-02
CZ290935B6 (cs) 2002-11-13
TR200103685T2 (tr) 2002-05-21
CA2375848A1 (en) 2000-12-21
ZA200110279B (en) 2003-05-28
ES2198319T3 (es) 2004-02-01
NO20016099D0 (no) 2001-12-14
CN1370172A (zh) 2002-09-18
HUP0201434A2 (en) 2002-08-28
US6670360B2 (en) 2003-12-30
RU2222541C2 (ru) 2004-01-27
DK1186607T3 (da) 2003-09-01
PL356479A1 (en) 2004-06-28
CZ20014505A3 (cs) 2002-05-15
DE60002860D1 (de) 2003-06-26
WO2000077003A1 (en) 2000-12-21
DE60002860T2 (de) 2004-05-06
KR100583663B1 (ko) 2006-05-26
CN1170829C (zh) 2004-10-13
KR20020022703A (ko) 2002-03-27
IL147088A (en) 2006-12-31

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO950297D0 (no) Prolinamidderivater
EP1535915A4 (de) Furan- oder thiophenderivat und dessen medizinische verwendung
CA2338311A1 (en) Prodrugs of the pyridyl methyl sulfinyl benzimidazoles
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
AU2804400A (en) Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
NO953305D0 (no) Antranilsyrederivat
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
IL205420A0 (en) Immunoregulatory compounds and derivatives
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
EP1396493A4 (de) Heterocyclische verbindungen
ATE327225T1 (de) Neue verwendung von benzothiazolderivaten
NO20014925D0 (no) Farmasöytiske forbindelser
WO2002008219A3 (en) 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
EP1092435A4 (de) Antidiabetische medikamente
ATE188702T1 (de) Thienodiazepinverbindungen und ihre verwendung
WO2003007954A3 (en) Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
HUP0201284A2 (hu) Hatóanyagként kinazolindionszármazék kimáz inhibitort tartalmazó gyógyászati készítmények fibrózis megelőzésére vagy kezelésére
DK0585722T3 (da) Benzimidazolderivater som antimikrobielt middel mod Campylobacter pylon
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
ATE240957T1 (de) Optisch aktive pyrrolopyridazin-derivate
DK1256581T3 (da) Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation
HUP0201282A2 (hu) Hatóanyagként kinazolindionszármazék kimázinhibitort tartalmazó gyógyászati készítmények dermatitisz megelőzésére és kezelésére

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application